UPDATE: JPMorgan Downgrades Karyopharm Therapeutics (KPTI) to Underweight
Tweet Send to a Friend
(Updated - August 6, 2021 4:15 AM EDT)
JPMorgan analyst Eric Joseph downgraded Karyopharm Therapeutics (NASDAQ: KPTI) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Eric Joseph downgraded Karyopharm Therapeutics (NASDAQ: KPTI) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
